Download PDF
Neuropediatrics 2018; 49(01): 035-043
DOI: 10.1055/s-0037-1607279
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Differentially Regulated Cell-Free MicroRNAs in the Plasma of Friedreich's Ataxia Patients and Their Association with Disease Pathology

Subrahamanyam Dantham   *
1   Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
,
Achal K. Srivastava
2   Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
,
Sheffali Gulati
3   Department of Paediatrics Neurology, All India Institute of Medical Sciences, New Delhi, India
,
Moganty R. Rajeswari
1   Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations
Further Information

Publication History

01 May 2017

28 August 2017

Publication Date:
27 November 2017 (online)

    Permissions and Reprints

Abstract

Friedreich's ataxia (FRDA) is a multisystem disease affecting the predominately nervous system, followed by muscle, heart, and pancreas. Current research focused on therapeutic interventions aimed at molecular amelioration, but there are no reliable noninvasive signatures available to understand disease pathogenesis. The present study investigates the alterations of plasma cell-free microRNAs (miRNAs) in FRDA patients and attempts to find the significance in relevance with the pathogenesis. Total RNA from the plasma of patients and healthy controls were subjected to miRNA microarray analysis using Agilent Technologies microarray platform. Differentially regulated miRNAs were validated by SYBR-green real-time polymerase chain reaction (Thermo Fisher Scientific). The study identified 20 deregulated miRNAs (false discovery rate < 0.01, fold change ≥ 2.0 ≤) in comparison with healthy controls; out of which 17 miRNAs were upregulated, and 3 miRNAs were downregulated. Target and pathway analysis of these miRNAs have shown association with neurodegenerative and other clinical features in FRDA. Further validation (n = 21) identified a set of significant (p < 0.05) deregulated miRNAs; hsa-miR-15a-5p, hsa-miR-26a-5p, hsa-miR-29a-3p, hsa-miR-223–3p, hsa-24–3p, and hsa-miR-21–5p in comparison with healthy controls. These miRNAs were reported to influence various pathological features associated with FRDA. The present study is expected to aid in the understanding of disease pathogenesis.

Keywords

Friedreich's ataxia - biomarker - ataxia - microRNA - miRNA

Funding

The authors received financial support from the Indian Council of Medical Research, New Delhi (ref. no. 5/4–5/85/Neuro/2012-NCD-I) for the research, authorship, and/or publication of this article. We acknowledge Department of Biotechnology, Government of India for providing research fellowship to D.S.


Ethical Approval

The study design was approved by the institute ethics committee (ref. no. IEC/NP-311/2012/RP-24/2012).


* The present address: National Institute of Malaria Research (Indian Council of Medical Research), New Delhi, India.


Supplementary Material

 

  • References

  • 1 Bürk K. Friedreich ataxia: current status and future prospects. Cerebellum Ataxias 2017; 4: 4
    CrossrefPubMedGoogle Scholar
  • 2 Delatycki MB, Corben LA. Clinical features of Friedreich ataxia. J Child Neurol 2012; 27 (09) 1133-1137
    CrossrefPubMedGoogle Scholar
  • 3 Dantham S, Srivastava AK, Gulati S, Rajeswari MR. Plasma circulating cell-free mitochondrial DNA in the assessment of Friedreich's ataxia. J Neurol Sci 2016; 365: 82-88
    CrossrefPubMedGoogle Scholar
  • 4 Campuzano V, Montermini L, Moltò MD. , et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271 (5254): 1423-1427
    CrossrefPubMedGoogle Scholar
  • 5 Jiralerspong S, Liu Y, Montermini L, Stifani S, Pandolfo M. Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo. Neurobiol Dis 1997; 4 (02) 103-113
    CrossrefPubMedGoogle Scholar
  • 6 Pastore A, Puccio H. Frataxin: a protein in search for a function. J Neurochem 2013; 126 (Suppl. 01) 43-52
    CrossrefPubMedGoogle Scholar
  • 7 Aranca TV, Jones TM, Shaw JD. , et al. Emerging therapies in Friedreich's ataxia. Neurodegener Dis Manag 2016; 6 (01) 49-65
    CrossrefPubMedGoogle Scholar
  • 8 Lynch DR, Deutsch EC, Wilson RB, Tennekoon G. Unanswered questions in Friedreich ataxia. J Child Neurol 2012; 27 (09) 1223-1229
    CrossrefPubMedGoogle Scholar
  • 9 Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA?. RNA 2005; 11 (12) 1753-1761
    CrossrefPubMedGoogle Scholar
  • 10 Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120 (01) 15-20
    CrossrefPubMedGoogle Scholar
  • 11 Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12 (12) 861-874
    CrossrefPubMedGoogle Scholar
  • 12 Li Y, Kowdley KV. MicroRNAs in common human diseases. Genomics Proteomics Bioinformatics 2012; 10 (05) 246-253
    CrossrefPubMedGoogle Scholar
  • 13 Viswambharan V, Thanseem I, Vasu MM, Poovathinal SA, Anitha A. miRNAs as biomarkers of neurodegenerative disorders. Biomarkers Med 2017; 11 (02) 151-167
    CrossrefPubMedGoogle Scholar
  • 14 Mahishi LH, Hart RP, Lynch DR, Ratan RR. miR-886-3p levels are elevated in Friedreich ataxia. J Neurosci 2012; 32 (27) 9369-9373
    CrossrefPubMedGoogle Scholar
  • 15 Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C. , et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011; 2: 282
    CrossrefPubMedGoogle Scholar
  • 16 Igoillo-Esteve M, Gurgul-Convey E, Hu A. , et al. Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia. Hum Mol Genet 2015; 24 (08) 2274-2286
    CrossrefPubMedGoogle Scholar
  • 17 Turchinovich A, Samatov TR, Tonevitsky AG, Burwinkel B. Circulating miRNAs: cell–cell communication function?. Front Genet 2013; 4: 19
    PubMedGoogle Scholar
  • 18 Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol 2016; 231 (01) 25-30
    CrossrefPubMedGoogle Scholar
  • 19 Keiser MS, Geoghegan JC, Boudreau RL, Lennox KA, Davidson BL. RNAi or overexpression: alternative therapies for spinocerebellar ataxia type 1. Neurobiol Dis 2013; 56: 6-13
    CrossrefPubMedGoogle Scholar
  • 20 Lamont PJ, Davis MB, Wood NW. Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients. Clinical and genetic correlates. Brain 1997; 120 (Pt 4): 673-680
    CrossrefPubMedGoogle Scholar
  • 21 Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736
    CrossrefPubMedGoogle Scholar
  • 22 Rodriguez-Lebron E, Liu G, Keiser M, Behlke MA, Davidson BL. Altered Purkinje cell miRNA expression and SCA1 pathogenesis. Neurobiol Dis 2013; 54: 456-463
    CrossrefPubMedGoogle Scholar
  • 23 Kemp KC, Cook AJ, Redondo J, Kurian KM, Scolding NJ, Wilkins A. Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia. Acta Neuropathol Commun 2016; 4 (01) 53
    CrossrefPubMedGoogle Scholar
  • 24 Koeppen AH, Mazurkiewicz JE. Friedreich ataxia: neuropathology revised. J Neuropathol Exp Neurol 2013; 72 (02) 78-90
    CrossrefPubMedGoogle Scholar
  • 25 Meng H, Larson SK, Gao R, Qiao X. BDNF transgene improves ataxic and motor behaviors in stargazer mice. Brain Res 2007; 1160: 47-57
    CrossrefPubMedGoogle Scholar
  • 26 Jones J, Estirado A, Redondo C, Bueno C, Martínez S. Human adipose stem cell-conditioned medium increases survival of Friedreich's ataxia cells submitted to oxidative stress. Stem Cells Dev 2012; 21 (15) 2817-2826
    CrossrefPubMedGoogle Scholar
  • 27 Jones J, Estirado A, Redondo C, Martinez S. Stem cells from wildtype and Friedreich's ataxia mice present similar neuroprotective properties in dorsal root ganglia cells. PLoS One 2013; 8 (05) e62807
    CrossrefPubMedGoogle Scholar
  • 28 McCormick KL, Wang X, Mick GJ. Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes. J Biol Chem 2006; 281 (01) 341-347
    CrossrefPubMedGoogle Scholar
  • 29 Cnop M, Igoillo-Esteve M, Rai M. , et al. Central role and mechanisms of β-cell dysfunction and death in Friedreich ataxia-associated diabetes. Ann Neurol 2012; 72 (06) 971-982
    CrossrefPubMedGoogle Scholar
  • 30 Amici M, Sagratini D, Pettinari A, Pucciarelli S, Angeletti M, Eleuteri AM. 20S proteasome mediated degradation of DHFR: implications in neurodegenerative disorders. Arch Biochem Biophys 2004; 422 (02) 168-174
    CrossrefPubMedGoogle Scholar
  • 31 Roy S, Khanna S, Hussain S-RA. , et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009; 82 (01) 21-29
    CrossrefPubMedGoogle Scholar
  • 32 Kida K, Nakajima M, Mohri T. , et al. PPARα is regulated by miR-21 and miR-27b in human liver. Pharm Res 2011; 28 (10) 2467-2476
    CrossrefPubMedGoogle Scholar
  • 33 García-Giménez JL, Gimeno A, Gonzalez-Cabo P. , et al. Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts. PLoS One 2011; 6 (06) e20666
    CrossrefPubMedGoogle Scholar
  • 34 Bravo-Egana V, Rosero S, Klein D. , et al. Inflammation-mediated regulation of microRNA expression in transplanted pancreatic islets. J Transplant 2012; 2012: 723614
    PubMedGoogle Scholar
  • 35 Shinde S, Mukhopadhyay S, Mohsen G, Kean Khoo S. Biofluid-based microRNA biomarkers for Parkinson's disease: an overview and update. AIMS Med Sci 2015; 2 (01) 15-25
    PubMedGoogle Scholar
  • 36 Yunta M, Nieto-Díaz M, Esteban FJ. , et al. MicroRNA dysregulation in the spinal cord following traumatic injury. PLoS One 2012; 7 (04) e34534
    CrossrefPubMedGoogle Scholar
  • 37 Yang Z, Zhong L, Xian R, Yuan B. MicroRNA-223 regulates inflammation and brain injury via feedback to NLRP3 inflammasome after intracerebral hemorrhage. Mol Immunol 2015; 65 (02) 267-276
    CrossrefPubMedGoogle Scholar
  • 38 Strickland IT, Richards L, Holmes FE, Wynick D, Uney JB, Wong L-F. Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons. PLoS One 2011; 6 (08) e23423
    CrossrefPubMedGoogle Scholar
  • 39 Zhou S, Yu B, Qian T. , et al. Early changes of microRNAs expression in the dorsal root ganglia following rat sciatic nerve transection. Neurosci Lett 2011; 494 (02) 89-93
    CrossrefPubMedGoogle Scholar
  • 40 Lu A, Huang Z, Zhang C. , et al. Differential expression of microRNAs in dorsal root ganglia after sciatic nerve injury. Neural Regen Res 2014; 9 (10) 1031-1040
    CrossrefPubMedGoogle Scholar